- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Ecogene 21
Total 1192 results
-
PETHEMA FoundationJanssen-Cilag, S.A.; Celgene-BMS; LIDESECNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterCelgene; Onyx/AmgenActive, not recruiting
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedPreviously Untreated Peripheral T-cell LymphomaUnited States
-
Institut CurieCelgene Corporation; Intergroupe Francophone du MyelomeCompleted
-
University of Wisconsin, MadisonGenentech, Inc.; Celgene CorporationCompletedLymphoma, Non-Hodgkin | Small Lymphocytic Lymphoma | Lymphoid LeukemiaUnited States
-
Washington University School of MedicineCelgene; Seagen Inc.CompletedLymphoma, Large B-Cell, DiffuseUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLC; Celgene CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom, Belgium, Germany
-
Mehrdad Abedi, MDCelgeneTerminated
-
University Hospital, ToulouseCelgene; Intergroupe Francophone du MyelomeCompleted
-
Psoriasis Treatment Center of Central New JerseyCelgeneCompletedPlaque PsoriasisUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedMultiple MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterNovartis; CelgeneCompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin Lymphoma | Adult Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
Institut de Cancérologie de la LoireCelgene CorporationCompletedLeukemia, Lymphoid | Precursor B-Cell Lymphoblastic Leukemia-LymphomaFrance
-
Groupe Francophone des MyelodysplasiesRoche Pharma AG; CelgeneCompletedMyelodysplastic SyndromesFrance, Monaco
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Celgene CorporationCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Australia
-
Vanderbilt UniversityNational Cancer Institute (NCI); Celgene CorporationCompletedOvarian CancerUnited States
-
University of Michigan Rogel Cancer CenterCelgene CorporationTerminatedBladder Cancer | Urothelial CancerUnited States
-
Kenneth Peters, MDCelgene CorporationCompleted
-
Mt. Sinai Medical Center, MiamiBayer; Celgene CorporationCompletedMalignant MelanomaUnited States
-
Eugene F Yen, MDRecruitingMicroscopic ColitisUnited States
-
Weill Medical College of Cornell UniversityAstraZeneca; Celgene CorporationActive, not recruitingMantle Cell LymphomaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneBristol-Myers SquibbCompletedNeoplasms | Neoplasms by Histologic Type | Lymphoma | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Immune System DisorderUnited States
-
Fundación General de la Universidad de SalamancaCelgene CorporationCompletedMyelodysplastic SyndromeGermany, Spain, France
-
Fox Chase Cancer CenterMerck Sharp & Dohme LLC; CelgeneTerminatedNonsmall Cell Lung Cancer | Relapsed or Refractory Solid TumorsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMultiple MyelomaUnited States
-
US Oncology ResearchUniversity of Southern California; Celgene CorporationCompleted
-
Weill Medical College of Cornell UniversityPfizer; Celgene CorporationTerminatedMultiple MyelomaUnited States
-
AHS Cancer Control AlbertaAlberta Cancer Foundation; Celgene CorporationCompleted
-
Indiana University School of MedicineCelgene CorporationTerminatedHepatocellular CarcinomaUnited States
-
Groupe Francophone des MyelodysplasiesRoche Pharma AG; Celgene CorporationCompleted
-
IRCCS Centro di Riferimento Oncologico della BasilicataCelgene CorporationCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Celgene CorporationCompletedMyelodysplasiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); CelgeneRecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome With Excess Blasts | IDH2 Gene Mutation | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 20-30 Percent of Bone Marrow Nucleated CellsUnited States
-
Psoriasis Treatment Center of Central New JerseyCelgene CorporationCompleted
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada
-
Alliance Foundation Trials, LLC.Bristol-Myers Squibb; Celgene CorporationTerminatedNonsmall Cell Lung Cancer | Non Small Cell Lung Cancer Recurrent | Non-Small Cell Carcinoma of Lung, TNM Stage 4 | Non-Small-Cell Lung Cancer MetastaticUnited States
-
Weiyun AiCelgene CorporationCompletedLymphoma | T-Cell Lymphoma | Cutaneous LymphomaUnited States
-
University of LeedsCelgene Corporation; Oncolytics Biotech; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompleted
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI); Celgene CorporationCompletedMultiple MyelomaUnited States
-
University of California, DavisEli Lilly and Company; CelgeneTerminatedBreast Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Thomas KippsCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieMerck Sharp & Dohme LLC; Celgene CorporationTerminatedPeripheral T-Cell Non-Hodgkin's LymphomaAustria
-
Center Eugene MarquisLigue contre le cancer, FranceRecruiting
-
Queen Mary University of LondonMedical Research Council; CelgeneNot yet recruiting
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Wake Forest University Health SciencesCelgene; Amgen; Janssen, LPActive, not recruitingMultiple MyelomaUnited States